Author Archive

The Case Of The Vaccination Profiteers

The Case Of The Vaccination Profiteers

The American Academy of Pediatrics announced the submission of an amicus brief to the US Supreme Court on July 30, 2010, “joined by 21 partnering health organizations,” in the vaccine injury case of Bruesewitz v Wyeth, to support the powerful vaccine maker against a lone family. Oral arguments in the case took place on October […]

The Psychopharmaceutical Industrial Complex

The Psychopharmaceutical Industrial Complex

The Psychopharmaceutical Industrial Complex (PPIC) is a symbiotic system composed of the American Psychiatric Association, the pharmaceutical industry, public relations and advertising firms, patient support organizations, the National Institute of Mental Health, managed care organizations, and the flow of resources and money among these groups, according to an October 1, 2009 paper in the Journal of Mental Health Counseling, by Dr Thomas Murray, director of Counseling and Disability Services at the University of North Caroline School of Art.

Tax Dollars Used To Fund ‘Preemptive Drugging’

Tax Dollars Used To Fund ‘Preemptive Drugging’

Tax dollars are being used to fuel the American epidemic of mental illness by promoting the preemptive drugging of persons supposedly at risk of developing mental disorders, to the great benefit of the pharmaceutical industry. In March 2010, the US Department of Health & Human Services Substance Abuse & Mental Health Service Administration Center for Mental Health Services announced $16.5 million in funding for “Mental Health Transformation Grants,” one of SAMHSA’s services grant programs.

Tracking the American Epidemic of Mental Illness

Tracking the American Epidemic of Mental Illness

Over a twenty-year span, starting when Prozac came on the market in 1987, the number of people on government disability due to mental illness went from 1.25 million to more than 4 million today. There has been a 35-fold increase in the number of children disabled by mental illness who receive federal disability payments, rising from 16,200 in 1987, to 561,569 in 2007.

More Warnings Needed on Reglan Side Effects

More Warnings Needed on Reglan Side Effects

Although a black box warning for tardive dyskinesia was announced by the FDA in February 2009, lawsuits filed against the makers of Reglan (metoclopramide) allege the drug companies knew for decades that the risk of movement disorders was much greater than acknowledged in previous labels. According to an expert witness report filed in a Georgia lawsuit by Dr Robert Nelson, a former 20-year employee of the FDA and National Institute of Health, “the 1/500 EPS labeling was inaccurate and misleading from the moment the oral dosage form was approved.”

Prescribing Psychiatric Drugs To Infants, Toddlers A Lucrative Business

Prescribing Psychiatric Drugs To Infants, Toddlers A Lucrative Business

Of all the harmful actions of modern psychiatry, “the mass diagnosing and drugging of children is the most appalling with the most serious consequences for the future of individual lives and for society,” warns the world-renowned expert, Dr Peter Breggin, often referred to as the “Conscience of Psychiatry.” “We’re bringing up a generation in this country in which you either sit down, shut up and do what you’re told, or you get diagnosed and drugged,” he points out.

Psychiatric Drugging of Infants and Toddlers in the US

Psychiatric Drugging of Infants and Toddlers in the US

The United States has become the psychiatric drugging capital of the world for kids with children being medicated at a younger and younger age. Medicaid records in some states show infants less than a year old on drugs for mental disorders. The use of powerful antipsychotics with privately insured children, aged 2 through 5 in the US, doubled between 1999 and 2007, according to a study of data on more than one million children with private health insurance in the January, 2010, “Journal of the American Academy of Child & Adolescent Psychiatry.”

Number Of Paxil-Related Birth Defect Cases Soar

Number Of Paxil-Related Birth Defect Cases Soar

Since Paxil came on the market in 1992, there have been three separate types of failure to warn lawsuits filed against GlaxoSmithKline over Paxil; birth defects, suicide, and addiction. Roughly 150 suicide cases were settled for an average of about $2 million, and about 300 cases involving suicide attempts were settled for an average of $300,000.

Ghostbusting In Paxil Birth Defect Litigation

Ghostbusting In Paxil Birth Defect Litigation

A month before the first Paxil birth defect trial against GlaxoSmithKline was set to begin, the Associated Press ran the headline, “Glaxo Used Ghostwriting Program to Promote Paxil,” in reporting on a program called “CASPPER,” which allowed doctors to “take credit for medical journal articles mainly written by company consultants.”

Paxil Birth Defect Litigation – First Trial A Bust for Glaxo

Paxil Birth Defect Litigation – First Trial A Bust for Glaxo

GlaxoSmithKline has paid out close to $1 billion to resolve lawsuits involving Paxil since the drug came on the market in 1992, according to a December 14, 2009 Bloomberg report. But the billion dollars does not cover the more than 600 Paxil birth defect cases currently pending in multilitigation in Pennsylvania.

Copyright © 2008 The Public Record. All rights reserved. Branding services provided by www.AndrewToschi.com Quantcast